C 17 Accuracy of existing diagnosis criteria for Behçet's disease (BD)

Davatchi, Fereydoun; Shahram, Farhad; Akbarian, M.; Gharibdoost, Farhad; Nadji, Abdolhadi; Chams, C.; Chams, Hormoz; Mansoori, Parisa; Shafai, N.

doi:10.1016/s0248-8663(05)82264-7

Cited by 17 publications

(33 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first validation study done on 1993 [7] showed lower sensitivity (86.2 %) of ISG with a higher specificity (97.5 %).This validation study was from Iran, which gave 366 of 886 patients of the ISG cohort of patients [16]. As the results were not as good as expected, the race to create better criteria continued.…”

Section: Validation Studies Leading To New Criteriamentioning

confidence: 99%

See 1 more Smart Citation

Classification and Diagnosis Criteria for Behçet’s Disease

et al. 2013

View full text Add to dashboard Cite

Section: Validation Studies Leading To New Criteriamentioning

confidence: 99%

“…A patient who has 3 major or 2 major and 2 minor manifestations is classified as BD. Mason and Barnes criteria have low sensitivity and high specificity [2,3,7,8].…”

mentioning

confidence: 99%

Classification and Diagnosis Criteria for Behçet’s Disease

et al. 2013

View full text Add to dashboard Cite

“…Also, they found that the accuracy of these criteria were 85.5% and 97.3%, respectively. 10 The sensitivity and specifity of ISG criteria in China was found to be 65.4% and 87.0%. 16 The sensitivity and specifity of ICBD were 87.0% and 94.1%, respectively.…”

mentioning

confidence: 96%

“…9 Davatchi presented Iranian criteria of BD in 1993 to overcome the low sensitivity of the ISG criteria. 10 Finally, the International Criteria for Behcet's disease (ICBD) was developed in 2006. 11,12 The clinical manifestations of BD differ widely in different ethnic groups.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Comparison of International Study Group Criteria and International Criteria for Behcet's Disease in the Azeri population of Iran

Delnabi¹,

Ghojehzadeh²,

Hajialilo³

et al. 2017

J Anal Res Clin Med

View full text Add to dashboard Cite

Behcet's disease (BD) is a chronic systemic inflammatory disease affecting multiple organs and systems such as mucosa, skin, eye, joints and cardiovascular, nervous and gastrointestinal systems. Various criteria are proposed for the assessment of BD. This study was designed to compare performance of two internationally collaborated criteria for diagnosis of BD, namely International Study Group (ISG) criteria and International Criteria for Behcet's Disease (ICBD) in the Azeri population of Iran.In a descriptive analytical study, 859 consecutive patients with one of the major clinical manifestations of BD were included. All patients were examined and evaluated by an expert rheumatologist and diagnosis was confirmed clinically. All patients were assessed by ISG and ICBD criteria. Finally, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of both criteria were calculated.We included 859 patients in this study. BD was diagnosed in 211 patients. Sensitivity, specificity and accuracy of ISG criteria were 64.9%, 100%, and 91.4%, respectively. Sensitivity, specificity and accuracy of ICBD criteria were 94.7%, 99.6% and 98.5%, respectively.Based on the finding of the present study, sensitivity and accuracy of ICBD criteria for diagnosis of BD in Azeri population are higher than ISG criteria. So we propose to use ICBD criteria for the evaluation of patients with suspected BD to decrease the rate of missed diagnosis.

show abstract

Behcet’s disease: epidemiology, clinical manifestations, and diagnosis

Davatchi

Chams‐Davatchi

Shams

et al. 2016

Expert Review of Clinical Immunology

291

190

View full text Add to dashboard Cite

Behcet's Disease (BD) is classified among vasculitides. The aim of this review was to put together different known reports in order to help the reader to better understand the disease, to avoid the frequent misdiagnosis, and to decide the best treatment. Areas covered: a) Epidemiology: BD is rare, and is seen along the Silk Road, from 20 to 420/100,000 in Turkey and 80/100,000 in Iran, to 0.64/100,000 in the UK. b) Clinical manifestations: oral aphthosis is seen in more than 95% of patients, genital aphthosis (60-90%), skin (pseudofolliculitis/erythema nodosum, 40-90%), eyes (uveitis/retinal vasculitis, 45-90%), gastrointestinal (diarrhea/hemorrhage/perforation/pain, 4-38%), vascular (venous/arterial thrombosis, aneurysm, 2.2-50%), neurological (all kinds, especially meningo-encephalitis, 2.3-38.5%), and articular (arthralgia/arthritis/ankylosing spondylitis, 11.6-93%). c) Pathergy test is positive in some patients: 8.6% (in India) to 70.7% (in China). This data was extracted from the five nationwide surveys and the largest case series from BD conference reports and a Pubmed search. Expert commentary: Diagnosis is clinical but classification/diagnosis criteria may help. The best criteria for BD is the International Criteria for Behcet's Disease (ICBD). BD is a multisystem disease progressing by attacks and remissions. Each attack may resemble the preceding or it may be different in duration, severity, and the systems involved.

show abstract

C 17 Accuracy of existing diagnosis criteria for Behçet's disease (BD)

Cited by 17 publications

References 0 publications

Classification and Diagnosis Criteria for Behçet’s Disease

Classification and Diagnosis Criteria for Behçet’s Disease

Comparison of International Study Group Criteria and International Criteria for Behcet's Disease in the Azeri population of Iran

Behcet’s disease: epidemiology, clinical manifestations, and diagnosis

Contact Info

Product

Resources

About